Severe Hemophilia A Completed Phase 1 Trials for Antihemophilic factor human (DB13192)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02083965Pharmacokinetics of rFVIIIFc at Two Vial StrengthsTreatment
NCT04864743A Study to Evaluate the Pharmacokinetics´╝îSafety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionTreatment